FTII
FutureTech II Acquisition Corp.Company Information
- Company Name
- FutureTech II Acquisition Corp.
- CIK
- CIK0001889450
- Category
- <br>Emerging growth company
- Ticker: Exchange
- FTII: OTC, FTIIU: OTC, FTIIW: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- FTII
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2024-12-31
- Institutional shares owned
- 969,497
- Shares outstanding
- 2,536,540
- Ownership
- 38.22%
Earnings Market Reaction
- Filing date
- 2025-08-22
- Price on filing date
- —
- 1-month reaction
- -2.28%
- 3-month reaction
- -2.28%
Balance Sheet
Values in millions ($)| Line item | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 1 | ||||||
| Other Assets Current | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Other Receivables | - | - | - | 2 | 2 | 2 | - | 0 | - | - | - | - | ||||||
| Marketable Securities Noncurrent | 9 | 9 | 26 | 27 | 27 | 26 | 62 | 61 | 124 | 121 | 119 | 118 | ||||||
| Prepaid Expense Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Assets | 11 | 11 | 28 | 28 | 28 | 28 | 63 | 62 | 124 | 122 | 119 | 119 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Taxes Payable Current | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | - | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 7 | 7 | 24 | 6 | 6 | 6 | 5 | 5 | 4 | 2 | 1 | 0 | ||||||
| Other Loans Payable Current | 0 | 0 | 18 | - | - | - | - | - | - | - | - | - | ||||||
| Notes Payable Current | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 1 | 0 | 0 | ||||||
| Liabilities | 10 | 11 | 28 | 10 | 9 | 9 | 8 | 8 | 7 | 6 | 4 | 4 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | 10 | - | - | - | 26 | 26 | 61 | 60 | 122 | 121 | 118 | 118 | ||||||
| Shares Outstanding | - | - | - | - | - | - | - | 1 | 0 | 5 | - | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -10 | -9 | -9 | -8 | -7 | -7 | -6 | -6 | -5 | -5 | -3 | -3 | ||||||
| Retained Earnings Accumulated Deficit | -10 | -9 | -9 | -8 | -7 | -7 | -6 | -6 | -5 | -5 | -3 | -3 | ||||||
| Liabilities And Stockholders Equity | 11 | 11 | 28 | 28 | 28 | 28 | 63 | 62 | 124 | 122 | 119 | 119 | ||||||
| Temporary Equity Redemption Price Per Share | - | - | - | - | - | - | - | 10.74 | 10.49 | 10.49 | 10.30 | 10.20 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialFutureTech II Acquisition Corp. (FTII) — SEC Financial Statements & Analysis
FutureTech II Acquisition Corp. (FTII) is a biological products, (no diagnostic substances) company. FutureTech II Acquisition Corp. trades on OTC as: FTII, FTIIU, FTIIW. FutureTech II Acquisition Corp. (FTII)'s most recent SEC filing is a Form 10-Q for the period ended 2025-06-30, filed with the SEC on 2025-08-22. Based on that filing, FutureTech II Acquisition Corp. carries a market cap of $9.12M, a P/E ratio of -7.59x, a P/B ratio of -0.95x, an enterprise value of $12.50M, and an EV/EBITDA multiple of -12.30x. On profitability, it posts a Return on Equity (ROE) of 14.18% and a Return on Assets (ROA) of -6.19%. Per share, it reports EPS of $-1.54, diluted EPS of $-1.54, free cash flow per share of $-3.23, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -188.87% year-over-year and EPS growth of -364.31% year-over-year. On the balance sheet, it maintains a current ratio of 0.21x, a quick ratio of 0.20x, working capital of $-5.48M, a debt-to-equity ratio of -1.08x, a debt ratio of 0.98, free cash flow of $-2.52M (TTM), and net debt of $3.38M. Figures sourced from SEC EDGAR.
- Market Cap
- $9.12M
- P/E TTM
- -7.59x
- EPS TTM
- $-1.54
- P/B TTM
- -0.95x
- ROE TTM
- 14.18%
- ROA TTM
- -6.19%
- Debt To Equity
- -1.08x
- Free Cash Flow TTM
- $-2.52M
Data as of 2025-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is FutureTech II Acquisition Corp. in?
FutureTech II Acquisition Corp. (FTII) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does FTII trade on?
FutureTech II Acquisition Corp. (FTII) trades on the OTC.
When was FutureTech II Acquisition Corp. (FTII)'s most recent SEC filing?
FutureTech II Acquisition Corp. (FTII)'s most recent SEC filing is a Form 10-Q for the period ended 2025-06-30, filed with the SEC on 2025-08-22.
What is FTII's market cap?
FutureTech II Acquisition Corp. (FTII) has a market capitalization of $9.12M as of 2025-06-30.
What is FTII's EPS (earnings per share)?
FutureTech II Acquisition Corp. (FTII)'s trailing twelve month EPS is $-1.54 as of 2025-06-30.
What is FTII's ROE (return on equity)?
FutureTech II Acquisition Corp. (FTII)'s trailing twelve month Return on Equity (ROE) is 14.18% as of 2025-06-30.
What is FTII's ROA (return on assets)?
FutureTech II Acquisition Corp. (FTII)'s trailing twelve month Return on Assets (ROA) is -6.19% as of 2025-06-30.
What is FTII's EV/EBITDA?
FutureTech II Acquisition Corp. (FTII)'s trailing twelve month EV/EBITDA is -12.30x as of 2025-06-30.